Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma.

被引：0
|
作者：
Hendrickson, R. [1 ]
Daniel, J. [2 ]
Andrews, W. [1 ]
Fischer, R. [2 ]
Manalang, M. [2 ]
Ricks, S. [2 ]
机构：
[1] Childrens Mercy Hosptial & Clin, Kansas City, MO USA
[2] Childrens Mercy Hosp & Clin, Kansas City, MO USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B1070
引用
收藏
页码：721 / 721
页数：1
相关论文
共 9 条
  • [1] Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma
    Hendrickson, R.
    Daniel, J.
    Andrews, W.
    Fischer, R.
    Manalang, M.
    Ricks, S.
    TRANSPLANTATION, 2014, 98 : 721 - 721
  • [2] Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma
    Hendrickson, Richard J.
    Sujka, Joseph
    Fischer, Ryan
    Manalang, Michelle
    Daniel, James
    Andrews, Walter S.
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [3] Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma-2 Year Follow-Up
    Hendrickson, R.
    Andrews, W.
    Davis, M.
    Cisneros, R.
    Fischer, R.
    Daniel, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 767 - 767
  • [4] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    TRANSPLANTATION, 2014, 98 : 239 - 240
  • [5] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 239 - 240
  • [6] A prospective randomized study to compare the efficacy and safety of sirolimus(SLR) and mycophenolate mofetil(MMF) monitored by protocol biopsies in tacrolimus(TAC) based steroid free immunosuppression.
    Kumar, MSA
    Heifets, M
    Fyfe, B
    Sierka, D
    Saeed, MI
    Parekh, M
    Moritz, MJ
    Stabler, S
    Kumar, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 216 - 216
  • [7] Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation
    Nair, Satheesh
    Lipscomb, Jeannie
    Eason, James
    TRANSPLANTATION, 2008, 86 (03) : 418 - 422
  • [8] The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain, A
    Mazariegos, G
    Pokharna, R
    Parizhskaya, M
    Kashyap, R
    Kosmach-Park, B
    Smith, A
    Fung, JJ
    Reyes, J
    TRANSPLANTATION, 2003, 75 (07) : 1020 - 1025
  • [9] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION
    Saliba, F.
    Kaiser, G. M.
    De Carlis, L.
    Metselaar, H. J.
    De Simone, P.
    Duvoux, C.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S362 - S362
1